Ironwood Financial’s Bristol-Myers Squibb BMY Stock Holding History
Bought
Maintained
Sold
Other funds holding BMY
AIM
FWIA
DLA
Ironwood Financial's BMY Position: Q2 2026 in Review
Ironwood Financial reduced its Bristol-Myers Squibb (BMY) stake by 0.82% in Q2 2026, selling an estimated $4.31K and leaving 9,054 shares worth $537K. The position accounts for 0.08% of the portfolio, ranked #116.
Ironwood Financial first reported a position in BMY in Q4 2014 and has held it in 28 quarters since. The position peaked at $1.06M in Q2 2022. 889 funds tracked by Wall St. Rank hold BMY as of Q2 2026.
- Ironwood Financial held 9,054 shares of Bristol-Myers Squibb worth $537K as of Q2 2026.
- Ironwood Financial sold 75 Bristol-Myers Squibb shares in Q2 2026, an estimated $4.31K.
- Bristol-Myers Squibb made up 0.08% of Ironwood Financial's portfolio in Q2 2026, its #116 holding.
- Ironwood Financial first reported a position in Bristol-Myers Squibb in Q4 2014 and has held it in 28 quarters since.
- Ironwood Financial's Bristol-Myers Squibb position peaked at $1.06M in Q2 2022.
- 889 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q2 2026.
Based on Ironwood Financial's 13F filing for Q2 2026, filed 17 Jul 2026.